Pomalidomide-Associated Pulmonary Toxicity
- 1 January 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of Sport Medicine
- Vol. 28 (1), e143-e144
- https://doi.org/10.1097/mjt.0000000000000870
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Management of treatment-emergent peripheral neuropathy in multiple myelomaLeukemia, 2011
- Acute Lung Toxicity Related to PomalidomideSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2011
- Multiple MyelomaAnnual Review of Medicine, 2011
- Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple MyelomaJournal of Clinical Oncology, 2009
- Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic MechanismCancer Research, 2009
- Thalidomide-induced pneumonitisEuropean Journal of Internal Medicine, 2008
- Thalidomide-Related Eosinophilic Pneumonia: A case report and brief literature reviewCases Journal, 2008
- Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological MalignanciesCanadian Respiratory Journal, 2008
- Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed MyelomaJournal of Clinical Oncology, 2002
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981